Search research articles
Contact Us
Filters
Showing results (171-180 of 245) with videos related to
Page
of 25
Sort By:
Frontiers in Neurology
|
June 15, 2018
A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology
Serena Stanga, Liliana Brambilla, Bernadette Tasiaux, et al.
Pharmaceutical Development and Technology
|
January 11, 2013
Formulation of microspheres containing Crataegus monogyna Jacq. extract with free radical scavenging activity
Giulia Lucconi, Theodora Chlapanidas, Emanuela Martino, et al.
Frontiers in Immunology
|
April 11, 2022
Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
Dario Roccatello, Savino Sciascia, Stefano Murgia, et al.
Journal of Nephrology
|
January 25, 2020
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis
Savino Sciascia, Massimo Radin, Irene Cecchi, et al.
The Journal of Cell Biology
|
February 20, 2013
Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity
Davide Randazzo, Emiliana Giacomello, Stefania Lorenzini, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Short- and Long-Term Regulation of HuD: A Molecular Switch Mediated by Folic Acid?
Nicoletta Marchesi, Pasquale Linciano, Lucrezia Irene Maria Campagnoli, et al.
Journal of Neurochemistry
|
March 19, 2003
Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic
Tullio Florio, Domenico Paludi, Valentina Villa, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
September 19, 2003
Synthesis and pharmacological evaluation of new N-methyl-arylpyrrolidinols with analgesic activity
Simona Collina, Ornella Azzolina, Dina Vercesi, et al.
The Journal of Biological Chemistry
|
October 29, 2005
Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease
Daniela Rossi, Liliana Brambilla, Chiara F Valori, et al.
Lupus Science & Medicine
|
October 23, 2025
Administration of belimumab prior to standard immunosuppression in patients with early active lupus hinders accrual of new EULAR/ACR criteria within the first 12 months of treatment
Mariele Gatto, Claudio Cruciani, Elisa Bellis, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 245) with videos related to
Sort By:
Page
of 25
Frontiers in Neurology
|
June 15, 2018
A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology
Serena Stanga, Liliana Brambilla, Bernadette Tasiaux, et al.
Pharmaceutical Development and Technology
|
January 11, 2013
Formulation of microspheres containing Crataegus monogyna Jacq. extract with free radical scavenging activity
Giulia Lucconi, Theodora Chlapanidas, Emanuela Martino, et al.
Frontiers in Immunology
|
April 11, 2022
Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
Dario Roccatello, Savino Sciascia, Stefano Murgia, et al.
Journal of Nephrology
|
January 25, 2020
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis
Savino Sciascia, Massimo Radin, Irene Cecchi, et al.
The Journal of Cell Biology
|
February 20, 2013
Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity
Davide Randazzo, Emiliana Giacomello, Stefania Lorenzini, et al.
International Journal of Molecular Sciences
|
August 12, 2023
Short- and Long-Term Regulation of HuD: A Molecular Switch Mediated by Folic Acid?
Nicoletta Marchesi, Pasquale Linciano, Lucrezia Irene Maria Campagnoli, et al.
Journal of Neurochemistry
|
March 19, 2003
Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic
Tullio Florio, Domenico Paludi, Valentina Villa, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
September 19, 2003
Synthesis and pharmacological evaluation of new N-methyl-arylpyrrolidinols with analgesic activity
Simona Collina, Ornella Azzolina, Dina Vercesi, et al.
The Journal of Biological Chemistry
|
October 29, 2005
Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease
Daniela Rossi, Liliana Brambilla, Chiara F Valori, et al.
Lupus Science & Medicine
|
October 23, 2025
Administration of belimumab prior to standard immunosuppression in patients with early active lupus hinders accrual of new EULAR/ACR criteria within the first 12 months of treatment
Mariele Gatto, Claudio Cruciani, Elisa Bellis, et al.
Page
of 25